despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.
.
.
.
"it has been a long two years and throughout that time the western trust has not been assisting us in trying to understand the circumstances around our mother's death.
.